Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs sufentanil for postoperative analgesia in day-case ureteroscopic lithotripsy
ChiCTR2300079088Phase 4Recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in postoperative pain (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Pain VAS score at 4 hours after operation. Started Dec 2023; status: recruiting.
02
Drugs
oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300079088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079088.